The trial met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in progression-free survival
Under the proposed terms, Vaximm would secure a $20 million upfront payment, up to $815 million tied to clinical, regulatory, and commercial milestones
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
Datroway becomes the first and only therapy to show overall survival benefit versus chemotherapy in this difficult-to-treat patient population
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
cSCC is one of the most common cancers in the U.S. and globally
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
These medicines are essential in preventing RhD immunisation during pregnancy
Subscribe To Our Newsletter & Stay Updated
